Repurposing harmaline as a novel approach to reverse tmexCD1-toprJ1-mediated tigecycline resistance against klebsiella pneumoniae infections

Jindian Yang#,Lei Xu#,Yonglin Zhou,Minhe Cui,Dejun Liu,Jianfeng Wang,Yang Wang,Xuming Deng
DOI: https://doi.org/10.1186/s12934-024-02410-4
IF: 6.352
2024-05-26
Microbial Cell Factories
Abstract:A novel plasmid-mediated resistance–nodulation–division (RND) efflux pump gene cluster tmexCD1-toprJ1 in Klebsiella pneumoniae tremendously threatens the use of convenient therapeutic options in the post-antibiotic era, including the "last-resort" antibiotic tigecycline.
biotechnology & applied microbiology
What problem does this paper attempt to address?